Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.

Kwon GP, Gamba CS, Stefanick ML, Swetter SM, Li S, Shi RZ, Clarke CA, Feldman D, Millen AE, Messina C, Shikany JM, Manson JE, Chlebowski RT, Tang JY.

J Am Acad Dermatol. 2018 Jul;79(1):145-147. doi: 10.1016/j.jaad.2017.05.037. No abstract available.

PMID:
29908819
2.

Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women.

Banack HR, Stokes A, Fox MP, Hovey KM, Cespedes Feliciano EM, LeBlanc ES, Bird C, Caan BJ, Kroenke CH, Allison MA, Going SB, Snetselaar L, Cheng TD, Chlebowski RT, Stefanick ML, LaMonte MJ, Wactawski-Wende J.

Epidemiology. 2018 Sep;29(5):604-613. doi: 10.1097/EDE.0000000000000863.

PMID:
29864084
3.

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL.

JAMA Oncol. 2018 May 24:e181212. doi: 10.1001/jamaoncol.2018.1212. [Epub ahead of print]

PMID:
29800122
4.

Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials.

Shreibati JB, Manson JE, Margolis KL, Chlebowski RT, Stefanick ML, Hlatky MA.

Am Heart J. 2018 Apr;198:108-114. doi: 10.1016/j.ahj.2017.12.016. Epub 2017 Dec 27.

PMID:
29653631
5.

Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.

Kabat GC, Kim MY, Lane DS, Zaslavsky O, Ho GYF, Luo J, Nicholson WK, Chlebowski RT, Barrington WE, Vitolins MZ, Lin X, Liu S, Rohan TE.

Eur J Cancer Prev. 2018 May;27(3):261-268. doi: 10.1097/CEJ.0000000000000435.

PMID:
29438162
6.

Breast cancer survivorship: state of the science.

Pan K, Hurria A, Chlebowski RT.

Breast Cancer Res Treat. 2018 Apr;168(3):593-600. doi: 10.1007/s10549-017-4650-5. Epub 2018 Jan 13. Review.

PMID:
29332134
7.

Post-Stroke Cancer Risk among Postmenopausal Women: The Women's Health Initiative.

Sealy-Jefferson S, Cote ML, Chlebowski RT, Rexrode KM, Simon MS.

Womens Health Issues. 2018 Jan - Feb;28(1):29-34. doi: 10.1016/j.whi.2017.10.012. Epub 2017 Dec 2.

PMID:
29199053
8.

Serum lipids and risk of obesity-related cancers in postmenopausal women.

Kabat GC, Kim MY, Chlebowski RT, Vitolins MZ, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2018 Jan;29(1):13-24. doi: 10.1007/s10552-017-0991-y. Epub 2017 Dec 2.

PMID:
29197994
9.

Complexity of intermittent letrozole adjuvant therapy.

Chlebowski RT, Pan K.

Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9. Epub 2017 Nov 17. No abstract available.

PMID:
29158010
10.

Intentional weight loss and cancer risk.

Luo J, Hendryx M, Chlebowski RT.

Oncotarget. 2017 Sep 6;8(47):81719-81720. doi: 10.18632/oncotarget.20671. eCollection 2017 Oct 10. No abstract available.

11.

Association of Cataract Surgery With Mortality in Older Women: Findings from the Women's Health Initiative.

Tseng VL, Chlebowski RT, Yu F, Cauley JA, Li W, Thomas F, Virnig BA, Coleman AL.

JAMA Ophthalmol. 2018 Jan 1;136(1):3-10. doi: 10.1001/jamaophthalmol.2017.4512.

PMID:
29075781
12.

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.

Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, Manson JE, Chlebowski RT, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1730-1735. doi: 10.1158/1055-9965.EPI-17-0495. Epub 2017 Sep 22.

PMID:
28939589
13.

Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.

Park NJ, Chang Y, Bender C, Conley Y, Chlebowski RT, van Londen GJ, Foraker R, Wassertheil-Smoller S, Stefanick ML, Kuller LH.

PLoS One. 2017 Sep 21;12(9):e0184174. doi: 10.1371/journal.pone.0184174. eCollection 2017.

14.

Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx117.

PMID:
28922784
15.

Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.

Cheng TD, Song X, Beresford SAA, Ho GYF, Johnson KC, Datta M, Chlebowski RT, Wactawski-Wende J, Qi L, Neuhouser ML.

Cancer Causes Control. 2017 Oct;28(10):1053-1063. doi: 10.1007/s10552-017-0956-1. Epub 2017 Sep 12.

PMID:
28900765
16.

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J; WHI Investigators.

JAMA. 2017 Sep 12;318(10):927-938. doi: 10.1001/jama.2017.11217.

PMID:
28898378
17.

Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.

Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng TD, Chlebowski RT, Saquib N, Nassir R, Anderson G, Caan BJ.

Int J Cancer. 2017 Dec 1;141(11):2281-2290. doi: 10.1002/ijc.30931. Epub 2017 Aug 31.

PMID:
28833074
18.

Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health Initiative.

Thomson CA, Crane TE, Garcia DO, Wertheim BC, Hingle M, Snetselaar L, Datta M, Rohan T, LeBlanc E, Chlebowski RT, Qi L.

J Acad Nutr Diet. 2018 Apr;118(4):617-626. doi: 10.1016/j.jand.2017.06.010. Epub 2017 Aug 17.

PMID:
28826845
19.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA, Manson JE.

Menopause. 2018 Jan;25(1):11-20. doi: 10.1097/GME.0000000000000956.

PMID:
28816933
20.

Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.

Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG, Simon MS, Wactawski-Wende J, Wang A, Womack C, Manson JE.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1345-1348. doi: 10.1158/1055-9965.EPI-17-0096.

21.

Erratum to: Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures.

Kabat GC, Xue X, Kamensky V, Lane D, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2017 Sep;28(9):1007-1009. doi: 10.1007/s10552-017-0931-x. No abstract available.

PMID:
28752192
22.

Emerging combination endocrine therapies for advanced breast cancer.

Pan K, Lin EM, Chlebowski RT.

Breast J. 2018 Mar;24(2):214-215. doi: 10.1111/tbj.12876. Epub 2017 Jul 26. No abstract available.

PMID:
28744960
23.

Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, Howard BV, Rohan TE, Snetselar L, Lane D, Barrington W, Vitolins MZ, Womack C, Qi L, Hou L, Thomas F, Prentice RL.

J Clin Oncol. 2017 Sep 1;35(25):2919-2926. doi: 10.1200/JCO.2016.72.0326. Epub 2017 Jun 27.

PMID:
28654363
24.

Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.

Drieling RL, LaCroix AZ, Beresford SAA, Boudreau DM, Kooperberg C, Chlebowski RT, Ko MG, Heckbert SR.

J Am Geriatr Soc. 2017 Sep;65(9):1924-1931. doi: 10.1111/jgs.14911. Epub 2017 May 29.

PMID:
28555811
25.

Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.

Liang X, Margolis KL, Hendryx M, Reeves K, Wassertheil-Smoller S, Weitlauf J, Danhauer SC, Chlebowski RT, Caan B, Qi L, Lane D, Lavasani S, Luo J.

Cancer. 2017 Aug 15;123(16):3107-3115. doi: 10.1002/cncr.30688. Epub 2017 Apr 7.

PMID:
28387934
26.

Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.

Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G, McTiernan A, Chlebowski RT, Lane DS, Manson JE, Wactawski-Wende J, Pisano ED.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.

27.

Response.

Chlebowski RT, Pan K, Nananda F.

Breast Cancer Res Treat. 2017 Jun;163(3):633-634. doi: 10.1007/s10549-017-4197-5. Epub 2017 Mar 28. No abstract available.

PMID:
28353060
28.

Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).

Cauley JA, Danielson ME, Jammy GR, Bauer DC, Jackson R, Wactawski-Wende J, Chlebowski RT, Ensrud KE, Boudreau R.

J Clin Endocrinol Metab. 2017 May 1;102(5):1538-1547. doi: 10.1210/jc.2016-3589.

29.

Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies.

Yu D, Takata Y, Smith-Warner SA, Blot W, Sawada N, White E, Freedman N, Robien K, Giovannucci E, Zhang X, Park Y, Gao YT, Chlebowski RT, Langhammer A, Yang G, Severi G, Manjer J, Khaw KT, Weiderpass E, Liao LM, Caporaso N, Krokstad S, Hveem K, Sinha R, Ziegler R, Tsugane S, Xiang YB, Johansson M, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1060-1070. doi: 10.1158/1055-9965.EPI-16-0863. Epub 2017 Mar 6.

30.

Intentional Weight Loss and Endometrial Cancer Risk.

Luo J, Chlebowski RT, Hendryx M, Rohan T, Wactawski-Wende J, Thomson CA, Felix AS, Chen C, Barrington W, Coday M, Stefanick M, LeBlanc E, Margolis KL.

J Clin Oncol. 2017 Apr 10;35(11):1189-1193. doi: 10.1200/JCO.2016.70.5822. Epub 2017 Feb 6.

31.

Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative.

Arem H, Pfeiffer RM, Moore SC, Irwin ML, LaMonte MJ, Sarto GE, Nassir R, Luo J, Chlebowski RT, Brinton LA, Matthews CE.

PLoS One. 2017 Feb 2;12(2):e0171250. doi: 10.1371/journal.pone.0171250. eCollection 2017.

32.

Improving Breast Cancer Risk Assessment Versus Implementing Breast Cancer Prevention.

Chlebowski RT.

J Clin Oncol. 2017 Mar;35(7):702-704. doi: 10.1200/JCO.2016.70.9386. Epub 2016 Dec 28. No abstract available.

PMID:
28029306
33.

Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.

Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, Pee D, Chlebowski RT, Hines LM, Thompson CA, Gail MH.

J Natl Cancer Inst. 2016 Dec 20;109(2). doi: 10.1093/jnci/djw215. Print 2017 Feb.

34.

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

Wang A, Aragaki AK, Tang JY, Kurian AW, Manson JE, Chlebowski RT, Simon M, Desai P, Wassertheil-Smoller S, Liu S, Kritchevsky S, Wakelee HA, Stefanick ML.

Br J Cancer. 2017 Jan;116(3):e2. doi: 10.1038/bjc.2016.396. Epub 2016 Dec 6. No abstract available.

35.

Obesity and Cancer: Insights for Clinicians.

Goodwin PJ, Chlebowski RT.

J Clin Oncol. 2016 Dec 10;34(35):4197-4202. Epub 2016 Nov 7. No abstract available.

36.

Weight Loss Randomized Intervention Trials in Female Cancer Survivors.

Chlebowski RT, Reeves MM.

J Clin Oncol. 2016 Dec 10;34(35):4238-4248. Epub 2016 Nov 7. Review.

37.

Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome.

Lohmann AE, Goodwin PJ, Chlebowski RT, Pan K, Stambolic V, Dowling RJ.

J Clin Oncol. 2016 Dec 10;34(35):4249-4255. Epub 2016 Nov 7. Review.

PMID:
27903146
38.

Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.

Schonberg MA, Li VW, Eliassen AH, Davis RB, LaCroix AZ, McCarthy EP, Rosner BA, Chlebowski RT, Hankinson SE, Marcantonio ER, Ngo LH.

Breast Cancer Res Treat. 2016 Dec;160(3):547-562. doi: 10.1007/s10549-016-4020-8. Epub 2016 Oct 21.

39.

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Chlebowski RT, Pan K, Col NF.

Breast Cancer Res Treat. 2017 Jan;161(2):185-190. doi: 10.1007/s10549-016-4024-4. Epub 2016 Oct 26. Review.

PMID:
27785653
40.

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.

Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Chlebowski RT, Gass M, Crandall CJ, Womack CR, Heckbert SR.

Menopause. 2016 Nov;23(11):1168-1175.

41.

Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.

Chlebowski RT, Barrington W, Aragaki AK, Manson JE, Sarto G, OʼSullivan MJ, Wu D, Cauley JA, Qi L, Wallace RL, Prentice RL.

Menopause. 2017 Feb;24(2):133-141. doi: 10.1097/GME.0000000000000733.

42.

Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.

Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Lane DS, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE.

Int J Obes (Lond). 2017 Jan;41(1):170-177. doi: 10.1038/ijo.2016.179. Epub 2016 Oct 17.

PMID:
27748744
43.

Pet Ownership and Cancer Risk in the Women's Health Initiative.

Garcia DO, Lander EM, Wertheim BC, Manson JE, Volpe SL, Chlebowski RT, Stefanick ML, Lessin LS, Kuller LH, Thomson CA.

Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1311-6. doi: 10.1158/1055-9965.EPI-16-0218. Epub 2016 Jun 30.

44.

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K, Bao Y, Giovannucci EL, Ogino S, Stampfer MJ, Gaziano JM, Sesso HD, Buring JE, Cochrane BB, Chlebowski RT, Snetselaar LG, Manson JE, Fuchs CS, Wolpin BM.

J Clin Oncol. 2016 Aug 20;34(24):2899-905. doi: 10.1200/JCO.2015.66.3005. Epub 2016 Jun 20.

45.

Statin use and all-cancer survival: prospective results from the Women's Health Initiative.

Wang A, Aragaki AK, Tang JY, Kurian AW, Manson JE, Chlebowski RT, Simon M, Desai P, Wassertheil-Smoller S, Liu S, Kritchevsky S, Wakelee HA, Stefanick ML.

Br J Cancer. 2016 Jun 28;115(1):129-35. doi: 10.1038/bjc.2016.149. Epub 2016 Jun 9.

46.

Changing Adjuvant Breast-Cancer Therapy with a Signal for Prevention.

Chlebowski RT, Budoff MJ.

N Engl J Med. 2016 Jul 21;375(3):274-5. doi: 10.1056/NEJMe1606031. Epub 2016 Jun 5. No abstract available.

47.

Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative.

Tabung FK, Steck SE, Liese AD, Zhang J, Ma Y, Caan B, Chlebowski RT, Freudenheim JL, Hou L, Mossavar-Rahmani Y, Shivappa N, Vitolins MZ, Wactawski-Wende J, Ockene JK, Hébert JR.

Br J Cancer. 2016 May 24;114(11):1277-85. doi: 10.1038/bjc.2016.98. Epub 2016 Apr 21.

48.

Cardiovascular Disease After Aromatase Inhibitor Use.

Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RT.

JAMA Oncol. 2016 Dec 1;2(12):1590-1597. doi: 10.1001/jamaoncol.2016.0429.

PMID:
27100398
49.

Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.

Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED.

Breast Cancer Res Treat. 2016 Apr;156(3):567-576. doi: 10.1007/s10549-016-3773-4. Epub 2016 Apr 13.

50.

Physical Functioning among Women 80 Years of Age and Older With and Without a Cancer History.

Weaver KE, Leach CR, Leng X, Danhauer SC, Klepin HD, Vaughan L, Naughton M, Chlebowski RT, Vitolins MZ, Paskett E.

J Gerontol A Biol Sci Med Sci. 2016 Mar;71 Suppl 1:S23-30. doi: 10.1093/gerona/glv073.

Supplemental Content

Loading ...
Support Center